Home Itens selecionados Provedores de dados OAI Créditos Sobre Ajuda

			Busca avançada
	Provedor de dados AgEcon (1) Arq. Bras. Med. Vet. Zootec. (1) Autor Brandelli,A. (1) Castro,C.C. (1) Costa,G.A. (1) Fischer,G. (1) Garber, Lindsey (1) Hübner,S.O. (1) Lima,M. (1) Motta,A.S. (1) Silva e Silva,F. (1) Silva,D. Scopel e (1) Soares,M.P. (1) Vargas,G.D. (1) Mais... Palavra-chave Equine arteritis virus (2) Abortion (1) Antimicrobial peptide (1) Antiviral therapy (1) Breed (1) Breeding (1) EAV (1) EVA (1) Equid (1) Equine (1) Equine viral arteritis (1) Export (1) Foal (1) Horse (1) Livestock Production/Industries (1) Mare (1) NAHMS (1) Pony (1) Racing (1) Stallion (1) Mais... Tipo do documento Info:eu-repo/semantics/article (1) Report (1) Ano 2017 (1) 2000 (1) País Brazil (1) United States (1) Idioma Inglês (2)		Ordenar por:  Relevância Autor Título Ano Registros recuperados: 2 Primeira ... 1 ... Última EVA: EQUINE VIRAL ARTERITIS AND THE U.S. HORSE INDUSTRY AgEcon Garber, Lindsey. The National Animal Health Monitoring System (NAHMS) is sponsored by the USDA:APHIS:Veterinary Services (VS). The NAHMS Equine '98 Study was designed to provide information about the nation's equine population for education and research purposes. Equine viral arteritis population for education and research purposes. Equine viral arteritis (EVA) is an infectious disease caused by the equine arteritis virus (EAV). It can cause abortion in pregnant mares and death in young foals. Breeding stallions may become permanent carriers of the virus. Financial losses may include those due to abortion and/or disease and death in very young foals, reduced demand to breed and/or decreased commercial value of persistently infected stallions, and denied export market for... Tipo: Report Palavras-chave: NAHMS; Horse; Equine; Equid; Pony; Stallion; Mare; Foal; Breeding; Equine viral arteritis; EVA; Abortion; Virus; Export; EAV; Equine arteritis virus; Racing; Vaccination; Titer; Breed; Standardbred; Livestock Production/Industries. Ano: 2000 URL: http://purl.umn.edu/32749 Inhibition of equine arteritis virus by an antimicrobial peptide produced by Bacillus sp. P34 Arq. Bras. Med. Vet. Zootec. Silva,D. Scopel e; Castro,C.C.; Silva e Silva,F.; Costa,G.A.; Soares,M.P.; Vargas,G.D.; Fischer,G.; Lima,M.; Brandelli,A.; Motta,A.S.; Hübner,S.O.. ABSTRACT P34 is an antimicrobial peptide produced by Bacillus sp. P34, isolated from the intestinal contents of a fish from the Amazon basin. This peptide showed antibacterial properties against Gram-positive and Gram-negative bacteria and was characterized as a bacteriocin like substance. It was demonstrated that the peptide P34 exhibited antiviral activity against feline herpesvirus type 1 in vitro. The aim of this work was to evaluate P34 for its antiviral properties in vitro, using RK 13 cells, against the equine arteritis virus, since it has no specific treatment and a variable proportion of stallions may become persistently infected. The results obtained show that P34 exerts antiviral and virucidal activities against equine arteritis virus, probably... Tipo: Info:eu-repo/semantics/article Palavras-chave: Equine arteritis virus; Antiviral therapy; Antimicrobial peptide; Virucidal activity. Ano: 2017 URL: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0102-09352017000300535 Registros recuperados: 2 Primeira ... 1 ... Última

Empresa Brasileira de Pesquisa Agropecuária - Embrapa Todos os direitos reservados, conforme Lei n° 9.610 Política de Privacidade Área restrita		Embrapa Parque Estação Biológica - PqEB s/n° Brasília, DF - Brasil - CEP 70770-901 Fone: (61) 3448-4433 - Fax: (61) 3448-4890 / 3448-4891 SAC: https://www.embrapa.br/fale-conosco